Market Eyes LiveIQVIA Holdings Inc. (IQV) Stock Rating & Analysis
MELANY's data-driven read on IQVIA Holdings Inc. · Services-Commercial Physical & Biological Research.
Iqvia is a global provider of clinical research and technology solutions for the life sciences industry, formed in 2016 from the merger of Quintiles and IMS Health, which combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment delivers outsourced clinical development services covering drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process.
Why IQV scores 60/100
MELANY scores IQVIA Holdings Inc. 60/100 by weighing eight factors. Here is how IQV breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 17.9x, earnings growth accelerating
- PEG ratio 1.07 (< 1 = undervalued)
Margins, returns on capital, and balance-sheet strength.
- ROE 23%
Direction and relative strength of the recent share-price trend.
- Price +19.8% above 50-day MA
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for IQV
- High debt-to-equity ratio 2.6x, rate-sensitive balance sheet
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
IQVIA Holdings Inc. sits in the Healthcare sector theme, which MELANY currently rates 56/100 for strength. Theme strength feeds IQV's momentum and catalyst factors above.
Tracking IQV
IQVIA Holdings Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Create a free account to add IQV to your watchlist and get alerted the moment the rating changes.
How MELANY rates IQV
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. IQVIA Holdings Inc.'s 60/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about IQV
Is IQVIA Holdings Inc. (IQV) a buy?
As of 2026-08-25, MELANY rated IQVIA Holdings Inc. Hold with a composite score of 60/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is IQVIA Holdings Inc.'s MELANY score?
IQVIA Holdings Inc. (IQV) has a MELANY composite score of 60/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the IQV stock rating calculated?
MELANY scores IQV from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy IQVIA Holdings Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates IQVIA Holdings Inc. (IQV) Hold with a composite of 60/100 as of 2026-08-25. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the IQV stock price forecast?
MELANY does not publish price targets or forecasts for IQV. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 60/100 across eight factors for IQVIA Holdings Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is IQV stock overvalued or undervalued?
MELANY's valuation factor currently reads 54/100 for IQVIA Holdings Inc., where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives IQV's read.
What price should I buy IQV at?
MELANY is not flagging a fresh entry for IQV at its current Hold rating, so there is no entry zone to publish right now. Watchlisting IQV in the free app gets you alerted the moment that changes.
What are the risks of buying IQV stock?
The top risks MELANY currently flags for IQVIA Holdings Inc.: High debt-to-equity ratio 2.6x, rate-sensitive balance sheet; Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is IQVIA Holdings Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 40/100 for IQVIA Holdings Inc., and earnings track record, at 60/100. The 60/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will IQV stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 84/100 for IQV right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this IQV rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-25. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores IQV continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
IQV's live rating and alerts are free either way. The app is our flagship.